Opti Capital Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Opti Capital Management’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-860,221	Closed	-$98K	–	26
2018 Q4	$98K	Buy	+860,221	New	+$564K	0.05%	24

Other funds holding SGYP

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Opti Capital Management's SGYP Position: Q1 2019 in Review

Opti Capital Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 860,221 shares — an estimated $98K sold.

Opti Capital Management first reported a position in SGYP in Q4 2018 and held it in 1 quarter. The position peaked at $98K in Q4 2018. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

Opti Capital Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
Opti Capital Management sold 860,221 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $98K.
Opti Capital Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2018 and held it in 1 quarter.
Opti Capital Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $98K in Q4 2018.
12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.

Based on Opti Capital Management's 13F filing for Q1 2019, filed 13 May 2019.